HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

Abstract
In acute as well as chronic renal insufficiency significant immunological abnormalities were found: diminution of delayed hypersensitivity skin reactions, lymphopenia, reduction of the absolute but not relative number of peripheral blood T-lymphocytes. Responses of lymphocytes from uremic patients to PHA, allogeneic cells, or antigens were normal when lymphocyte cultures were preformed in allologous serum from a healthy individual. Sera from uremic patients had an inhibitory or toxic effect on stimulation of normal lymphocytes. Such an in vitro inhibitory activity was found not only in the whole serum but also when certain substances retained in renal failure (methylguanidine, larger molecules, etc.) were added in the lymphocyte cultures.
AuthorsJ L Touraine, F Touraine, J P Revillard, J Brochier, J Traeger
JournalNephron (Nephron) Vol. 14 Issue 2 Pg. 195-208 ( 1975) ISSN: 1660-8151 [Print] Switzerland
PMID1079332 (Publication Type: Journal Article)
Chemical References
  • Lectins
  • Tuberculin
  • Streptodornase and Streptokinase
Topics
  • Acute Kidney Injury (blood, immunology, therapy)
  • Cells, Cultured
  • Humans
  • Hypersensitivity, Delayed (immunology)
  • Immunity, Cellular
  • Immunosuppression Therapy
  • Kidney Failure, Chronic (blood, immunology, therapy)
  • Lectins (pharmacology)
  • Lymph Nodes (immunology, pathology)
  • Lymphocyte Activation
  • Lymphopenia (blood, etiology, immunology)
  • Renal Dialysis
  • Skin Tests
  • Streptodornase and Streptokinase (immunology)
  • T-Lymphocytes (drug effects, immunology)
  • Tuberculin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: